kff glp-1 1 in 8 adults in the US has taken Ozempic or another drug, survey finds Poll: 1 in 8 Adults

its a better-organized energy economy

Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: Theoretical consideration and therapeutic potential

Researchers screened 70 hypothyroid patients on tirzepatide, ultimately analyzing 17 who met strict criteria, including stable levothyroxine doses before starting tirzepatide and adequate follow-up data

Tablets: 4 mg, 8 mg (standard adult and pediatric oral doses)

Novo Nordisk announced that the FDA accepted a new drug application for a 25 mg oral version of semaglutide (Wegovy) for two new indications: Chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition Reduce the risk of major adverse cardiovascular events (MACE) in adults with obesity or overweight with established cardiovascular disease (CVD)